Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines
- 7 September 2010
- Vol. 28 (39), 6542-6548
- https://doi.org/10.1016/j.vaccine.2008.08.034
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Rotavirus and Severe Childhood DiarrheaEmerging Infectious Diseases, 2006
- Rotavirus Vaccines: Targeting the Developing WorldThe Journal of Infectious Diseases, 2005
- Efficacy of RIX4414 Live Attenuated Human Rotavirus Vaccine in Finnish InfantsThe Pediatric Infectious Disease Journal, 2004
- Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infantsVaccine, 2004
- The future of rotavirus vaccines: a major setback leads to new opportunitiesThe Lancet, 2004
- The estimation of mortality due to rotavirus infections in sub-Saharan AfricaVaccine, 2000
- Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countriesVaccine, 1999
- Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central AfricaResearch in Virology, 1991
- TRIAL OF AN ATTENUATED BOVINE ROTAVIRUS VACCINE (RIT 4237) IN GAMBIAN INFANTSThe Lancet, 1987
- FAILURE OF LIVE, ATTENUATED ORAL ROTAVIRUS VACCINEThe Lancet, 1986